Kang-Xin Wang
Internal medicineOncologyImmunotherapyNeoplasmTargeted therapyBiliary tract cancerSystemic chemotherapyImmune checkpoint inhibitorsPredictive biomarkerClinical trialMedicine
Publications 2
#1Poshita-Kumari Seesaha (Nanjing Medical University)H-Index: 1
#2Kang-Xin WangH-Index: 1
Last. Xiaofeng Chen (Nanjing Medical University)H-Index: 19
view all 9 authors...
Biliary tract cancer (BTC) is an uncommon and aggressive neoplasm, with most patients presenting in an advanced stage. Systemic chemotherapy is the limited treatment available but is unsatisfactory, while targeted therapy is still awaiting validation from clinical trials. Given the potential effect of immune checkpoint inhibitors (ICIs) in the treatment of BTC, this review aims to summarize the evidence-based benefits and predictive biomarkers for using inhibitors of cytotoxic T-lymphocyte-assoc...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.